- Cohen, DJ, Krumholz HM, Sukin CA et al, for the Stent Restenosis Study Investigators. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty: results from a randomised clinical trial. Circulation 1995; 92: 2480-2487.
- Karrilon Gl, Morice MC, Benveniste E et al. lntracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy: 30-day outcome of the French Multicentre Registiy. Circulation 1996; 94: 1519-1527.
- Albiero R, Hall P, ltoh A et al. Results of a consecutive series of patients receiving only antiplatelet therapy after optimal stent implantation: comparison of aspirin alone versus combined ticlopidine and aspirin therapy. Circulation 1997; 95: 1145-1156.
- de Jaegere P, Mudra H, Figulla H et al. Intravascular ultrasound guided optimised stent deployment. Immediate and 6 months clinical and angiographie results from the Multicentre Ultrasound Stenting in Coronaries Study (MUSIC study). Eur Heart) 1998; 19: 1214-1223.
- Fischman DL, Leon MB, Baim DS et al, for the Stent Restenosis Study investigators. A randomised comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331: 496-501.
- Serruys PW, de Jaegere P, Kiemeneij F et al, for the Benestent Study Group. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-495.
- De Cesare NB, Bartorelli AL, Guazzi M et al. Treatment of ostial lesions of the left anterior descending coronary artery with Palmaz-Schatz coronary stent. Am Heart J 1996; 132: 716-720.
- Serruys PW, Emanuelsson H, Van der Giessen W et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the BENESTENT-Il pilot study. Circulation 1996; 93: 412-422.
- The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein llb/llla receptor in high risk coronary angioplasty. N Engl J Med 1994; 330: 956-961.
- The EPILOG investigation. Platelet glycoprotein Ilb/IIIa receptor blockage and low-dose heparin during percutaneous coronary revascularisation. N Engl J Med 1997; 336: 1689-1696.
- Schomig A, Neumann FJ, Kastrati A et al. A randomised comparison of antiplatelet and anticoagulation therapy after the placement of coronary artery stents. N Engl J Med 1996; 334: 1084-1089.
- Fernandez-Aviles F, Alonso JJ, Duran JM et al. Subacute occlusion, bleeding complications, hospital stay and restenosis after Palmaz-Schatz coronary stenting under a new antithrombotic regime. J Am Coll Cardiol 1996; 27: 22-29.
International Journal of Cardiovascular Interventions
Volume 3, 2000 - Issue 3